Stock Events

Abcam 

$22.25
+$0.15+0.68% Wednesday 15:38

Statistics

Day High
22.25
Day Low
22.25
52W High
22.3
52W Low
22
Volume
4,002
Avg. Volume
0
Mkt Cap
5.12B
P/E Ratio
2,225
Dividend Yield
-
Dividend
-

Dividends

0%Dividend Yield
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Earnings

30JunExpected
Q3 2019
Q4 2019
Q1 2020
Q2 2020
Q3 2020
Q4 2020
Q1 2021
-0.04
0
0.04
0.08
Expected EPS
0
Actual EPS
0.0135

People Also Follow

This list is based on the watchlists of people on Stock Events who follow ABCZF. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Thermo Fisher Scientific
TMO
Mkt Cap234.95B
Thermo Fisher Scientific offers a wide range of research and diagnostic solutions, directly competing with Abcam's product offerings in antibodies and reagents.
Danaher
DHR
Mkt Cap194.5B
Danaher, through its subsidiaries like Cytiva and Pall Corporation, provides similar life sciences tools and consumables, competing in the biotechnology and research sectors.
Illumina
ILMN
Mkt Cap20.93B
Illumina provides genomic sequencing solutions that are essential for research, competing with Abcam's offerings in the genomics and proteomics space.
Agilent Technologies
A
Mkt Cap41.06B
Agilent Technologies offers a broad range of analytical instruments and reagents, directly competing with Abcam in the life sciences and diagnostics markets.
Bio-Rad Laboratories
BIO
Mkt Cap9.35B
Bio-Rad Laboratories provides a variety of research and clinical diagnostic products that overlap with Abcam's portfolio, especially in antibody-based technologies.
Repligen
RGEN
Mkt Cap8.45B
Repligen offers bioprocessing technologies and products that support the development of biologic drugs, competing with Abcam's solutions for drug discovery and development.
Bio-Techne
TECH
Mkt Cap11.73B
Bio-Techne operates in similar markets as Abcam, offering reagents, instruments, and custom manufacturing services for research and diagnostic applications.
Qiagen NV
QGEN
Mkt Cap10.16B
Qiagen is a provider of sample and assay technologies for molecular diagnostics, applied testing, academic and pharmaceutical research, competing in areas similar to Abcam's.
Mettler-Toledo International
MTD
Mkt Cap30.54B
Mettler-Toledo International offers precision instruments and services for research and development, competing with Abcam in the provision of lab equipment and supplies.
Waters
WAT
Mkt Cap20.56B
Waters Corporation specializes in analytical laboratory instrument and software, competing with Abcam in the life sciences sector, particularly in chromatography and mass spectrometry.

About

Biotechnology
Health Technology
Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. Its principal products include primary and secondary antibodies; conjugated antibodies and conjugation kits; singleplex and multiplex immunoassays; proteins and peptides that include cytokines; edited cell lines and lysates; and various other products, including cellular activity kits, miRNA kits, biochemicals, and cell signaling pathway tools. The company serves scientists and researchers in academic institutions and research institutes, as well as in pharmaceutical, biotechnology, and diagnostics companies. It has operations in the Americas, Europe, the Middle East, Africa, China, Japan, and rest of the Asia Pacific. The company sells its products online. Abcam plc was incorporated in 1998 and is headquartered in Cambridge, the United Kingdom.
Show more...
CEO
Murray Hennessy
Employees
1760
Country
GB
ISIN
GB00B6774699

Listings